Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELARL PHARMACIE GUILLEMOT-DELANNOY : revenue, balance sheet and financial ratios

SELARL PHARMACIE GUILLEMOT-DELANNOY is a French company founded 19 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in VERMENTON (89270), this company of category PME shows in 2023 a net income positive of 71 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-18

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL PHARMACIE GUILLEMOT-DELANNOY (SIREN 492278981)
Indicator 2023 2022 2021 2020 2018 2017 2016
Revenue N/C N/C N/C N/C N/C N/C N/C
Net income 71 192 € 122 621 € 73 070 € 89 567 € 81 176 € 126 240 € 201 121 €
EBITDA N/C N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2023, SELARL PHARMACIE GUILLEMOT-DELANNOY generates positive net income of 71 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2023: 201 k€ -> 71 k€.

Net income (2023) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

71 192 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 22%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 77%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2023) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

22.465%

Financial autonomy (2023) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

77.405%

Asset age ratio (2023) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

18.4%

Solvency indicators evolution
SELARL PHARMACIE GUILLEMOT-DELANNOY

Sector positioning

Debt ratio
22.46 2023
2021
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.22
Good

In 2023, the debt ratio of SELARL PHARMACIE GUILLEMO... (22.46) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
77.41% 2023
2021
2022
2023
Q1: 28.71%
Med: 48.51%
Q3: 68.18%
Excellent

In 2023, the financial autonomy of SELARL PHARMACIE GUILLEMO... (77.4%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 287.90. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2023) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

287.904

Liquidity indicators evolution
SELARL PHARMACIE GUILLEMOT-DELANNOY

Sector positioning

Liquidity ratio
287.9 2023
2021
2022
2023
Q1: 135.26
Med: 189.75
Q3: 270.27
Excellent

In 2023, the liquidity ratio of SELARL PHARMACIE GUILLEMO... (287.90) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Positioning of SELARL PHARMACIE GUILLEMOT-DELANNOY in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 220 transactions of similar company sales in 2023, the value of SELARL PHARMACIE GUILLEMOT-DELANNOY is estimated at 840 028 € (range 510 861€ - 1 180 891€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2023
220 transactions
510k€ 840k€ 1180k€
840 028 € Range: 510 861€ - 1 180 891€
NAF 5 année 2023

Valuation method used

Net Income Multiple
71 192 € × 11.8x = 840 028 €
Range: 510 861€ - 1 180 891€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE GUILLEMOT-DELANNOY with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMACIE GUILLEMOT-DELANNOY

What is the revenue of SELARL PHARMACIE GUILLEMOT-DELANNOY ?

The revenue of SELARL PHARMACIE GUILLEMOT-DELANNOY is not publicly disclosed (confidential accounts filed with INPI).

Is SELARL PHARMACIE GUILLEMOT-DELANNOY profitable?

Yes, SELARL PHARMACIE GUILLEMOT-DELANNOY generated a net profit of 71 k€ in 2023.

Where is the headquarters of SELARL PHARMACIE GUILLEMOT-DELANNOY ?

The headquarters of SELARL PHARMACIE GUILLEMOT-DELANNOY is located in VERMENTON (89270), in the department Yonne.

Where to find the tax return of SELARL PHARMACIE GUILLEMOT-DELANNOY ?

The tax return of SELARL PHARMACIE GUILLEMOT-DELANNOY is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE GUILLEMOT-DELANNOY operate?

SELARL PHARMACIE GUILLEMOT-DELANNOY operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.